Génomic Vision SA organizacji EPS
Jaka jest wartość EPS organizacji Génomic Vision SA?
Wartość EPS organizacji Génomic Vision SA to -0.10
Jaka jest definicja EPS?
Zysk na akcję (EPS) to zysk spółki na jedną akcję. Jest dostosowywany do rozcieńczenia i obliczany w ciągu dwunastu miesięcy.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS firm w Health Care sektor na EURONEXT w porównaniu do Génomic Vision SA
Czym się zajmuję organizacja Génomic Vision SA?
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Firmy z eps podobne do Génomic Vision SA
- Wartość EPS organizacji Mirasol Resources to -0.10
- Wartość EPS organizacji Kovo HealthTech to -0.10
- Wartość EPS organizacji Silver Bull Resources to -0.10
- Wartość EPS organizacji Sandfire Resources to -0.10
- Wartość EPS organizacji Winshine Science to -0.10
- Wartość EPS organizacji FRNT to -0.10
- Wartość EPS organizacji Génomic Vision SA to -0.10
- Wartość EPS organizacji Barings Global Short Duration High Yield Fund to -0.10
- Wartość EPS organizacji Numinus Wellness to -0.10
- Wartość EPS organizacji Nuchev to -0.10
- Wartość EPS organizacji Goodman Stapled Securities to -0.10
- Wartość EPS organizacji Umiya Tubes to -0.10
- Wartość EPS organizacji Auxly Cannabis to -0.10